- Home
- A-Z Publications
- Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)
- Previous Issues
- Volume 23, Issue 8, 2023
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) - Volume 23, Issue 8, 2023
Volume 23, Issue 8, 2023
-
-
Admission Avoidance for Older Adults Facilitated by Telemedicine during the COVID-19 Pandemic
Authors: Jemma Gregory, Benjamin Noble, Donna Ward, Zoe Wyrko and Luca LaghiIntroduction: The coronavirus pandemic has disproportionately affected older adults and has provided an incentive to find alternatives to emergency department attendance to avoid unnecessary exposure to the SARS-CoV-2 virus. To address this issue, a specialist geriatric multidisciplinary team at Queen Elizabeth Hospital set up a novel telemedicine approach to the ambulance service with the aim of reduc Read More
-
-
-
Nutraceuticals and Oral Supplements in Cancer Prevention: A Narrative Review
Background: Epidemiological studies have shown that food is a compelling means of maintaining a state of well-being and preventing diseases. Many malignant diseases are related to nutrition, and the nutrient-organism interaction could define the balance between health and disease. Nutrients and dietary components influence epigenetic phenomena and modify drug response so that food-organism interactions may i Read More
-
-
-
Thyroid Function: A Target for Endocrine Disruptors, Air Pollution and Radiofrequencies
Authors: Agostino Di Ciaula, Leonilde Bonfrate, Marica Noviello and Piero PortincasaThyroid diseases, including congenital hypothyroidism, thyroiditis, and childhood thyrotoxicosis, are progressively increasing. The incidence of thyroid cancer in children and adolescents has also increased in recent decades, mirroring the trends observed in adults. These epidemiologic trends develop in parallel with the rising costs associated with diagnosis and treatment of thyroid diseases. Both genetic and environme Read More
-
-
-
The Impact of COVID-19 Lockdown on Patients with Type 2 Diabetes Mellitus: A Brief Report
Background: The Italian population’s habits changed dramatically during the “COVID- 19 lockdown” due to physical distancing and self-isolation. Moreover, medical consultations of patients with chronic diseases, such as type 2 diabetes (T2D), were suspended or postponed, unless urgent or semi-urgent, for several consecutive months. Thus, it is expected that the lockdown could have affected glucometabolic control in T2D. Read More
-
-
-
Tirzepatide: A New Generation Therapeutic for Diabetes Type 2
Authors: Rami A. Al-Horani and Milad ChedidTirzepatide (mounjaro&®) is a derivative of the human glucose-dependent insulinotropic polypeptide (GIP) hormone with a position-20 being modified with 1,20-eicosanedioic acid via a chemical linker. It acts as a glucagon-like peptide-1 (GLP-1) receptor and GIP receptor agonist. It has recently been approved by FDA as an adjunct therapy to exercise and diet to improve glycemic control in patients with type II diabetes Read More
-
-
-
Effects of Sheng-Mai Injection on Diabetes Mellitus: A Systematic Review and Meta-analysis
Authors: Maoyi Yang, Zhipeng Hu and Rensong YueBackground: Diabetes mellitus (DM) is a metabolic disorder characterized by progressive β cell dysfunction. Sheng-Mai Injection (SMI), a Traditional Chinese medicine preparation, is widely used for DM and its related complications. Objective: This meta-analysis aimed to summarize the applications of SMI in DM and related complications. Methods: Eight databases were searched, and meta-analyses were performed. Res Read More
-
-
-
Use of Saliva to Assess the Adherence to Treatment with Oral Hypoglycemic Agents in Patients with Type 2 Diabetes
Background: The diagnosis of Type 2 Diabetes Mellitus (T2DM) is made by demonstrating the hypoglycemic condition, which involves the determination of plasma glucose, and the follow-up of hypoglycemic treatment is performed by assessing the glycated hemoglobin (HbA1c) concentration. Aim: The aim of this study was to evaluate the saliva as an alternative sample in assessing the adherence to treatment w Read More
-
-
-
Effects of SIRT1 on Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in Type 2 Diabetic Patients
Authors: Xiangqun Deng, Ling Deng, Min Xu, Yanlei Sun and Mei YangBackground: Patients with type 2 diabetes mellitus (T2DM) are at high risk for osteoporosis. SIRT1 plays an important regulatory role in the occurrence and development of diabetes mellitus; however, it is still not clear whether SIRT1 is directly related to the osteogenic ability of bone marrow mesenchymal stem cells (BMSCs) in T2DM patients. Methods: We obtained BMSCs from patients with T2DM and healthy volunte Read More
-
-
-
MiR-223-3p Aggravates Ocular Inflammation in Sjögren’s Syndrome
Authors: Xuan Qi, Ronghua Wang, Lu Jin, Yu Tian, Hongtao Jin, Yuxiang Han, Chao Sun, Meng Ding and Huifang GuoBackground and Objectives: Sjogren’s syndrome (SS) is a chronic autoimmune disease, particularly involving the lacrimal and salivary glands, with dryness as the main symptom. To date, the pathogenesis of SS is not fully understood. Recently, numerous miRNAs were implicated in SS etiology and pathogenesis. Methods: Ocular wash was collected from SS patients and healthy controls. INF-γ-treated salivary gland epithelial cell Read More
-
-
-
Effect of Calcitriol Treated Mesenchymal Stem Cells as an Immunomodulation Micro-environment on Allergic Asthma in a Mouse Model
Background: Allergic asthma is a chronic inflammatory illness of the respiratory system characterized by an increase in the number of inflammatory cells in the airways and trouble breathing. Mesenchymal stem cells (MSCs) have the potential to be used in inflammatory diseases as a cellular immunosuppressive treatment. They express calcitriol receptors and communicate with other immunocytes, which increases t Read More
-
-
-
Sodium Selenite Modulates Global Activation of Proinflammatory M1-like Macrophages, Necroinflammation and M1-like/M2-like Dichotomy at the Onset of Human Type 1 Diabetes
Authors: Mouna Nouar, Maroua Miliani, Imène Belhassena, Ahlam Fatmi and Mourad AribiAim: The study aims to show that sodium selenite (Ss) would have an immunomodulatory effect on the functional activity of proinflammatory macrophages (Mφs) during their extended extracellular activation at the onset of human type 1 diabetes (T1D). Background: Exacerbated activation of proinflammatory “M1” macrophages (Mφs) can promote chronic local pancreatic islet inflammation and T1D development. Read More
-
-
-
Novel 2,4- diaminopyrimidine 5-carboxamides as c-Jun N-terminal Kinase Inhibitors for Treating the Liver Fibrotic Disorder
By Surya K. DeDiaminopyrimidine compounds having the following general structure (I), compositions comprising an effective amount of a diaminopyrimidine compound, and methods for treating or preventing fibrotic liver disorders or other diseases associated with the JNK pathway are discussed in this patent study.
-
Volumes & issues
-
Volume 25 (2025)
-
Volume 24 (2024)
-
Volume 23 (2023)
-
Volume 22 (2022)
-
Volume 21 (2021)
-
Volume 20 (2020)
-
Volume 19 (2019)
-
Volume 18 (2018)
-
Volume 17 (2017)
-
Volume 16 (2016)
-
Volume 15 (2015)
-
Volume 14 (2014)
-
Volume 13 (2013)
-
Volume 12 (2012)
-
Volume 11 (2011)
-
Volume 10 (2010)
-
Volume 9 (2009)
-
Volume 8 (2008)
-
Volume 7 (2007)
-
Volume 6 (2006)
Most Read This Month
Article
content/journals/emiddt
Journal
10
5
false
en
